In clinical settings, giving DSIP intravenously has been shown to reduce pain in most patients with chronic pain, including those with migraines and psychogenic pain
Discovered in 2015 at USC, early studies showed it prevents diet-induced obesity in mice by enhancing fat oxidation
Not intended for human consumption .
It is a reduced-glutathione injection delivering 1200 mg of glutathione per vial, intended for intramuscular (I.M.) or intravenous (I.V.) administration by a licensed practitioner
Modulates cytokine synthesis - allowing the immune systems communication network to operate effectively
Some people notice improvements in energy, skin clarity, and overall wellness within a few weeks, while deeper cellular benefits and antioxidant support may take several weeks to months